Humana Inc. logo

Humana Inc.

HUM

NYSEHealthcareMedical - Healthcare Plans

Previous close

$378.87

−$1.86 · -0.49%

Aug 21, 4:00 PM ET

Pre-market

$378.88

+$0.01 · +0.00%

Aug 24, 7:09 AM ET

HUM company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

49

Fair Value

Momentum

68

Gaining

Sentiment

60

Mixed

Risk resilience

74

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.

Industry
Medical - Healthcare Plans
Sector
Healthcare
Headquarters
US
CEO
James A. Rechtin
Listed since
Dec 31, 1981
Employees
67,060

Market position

Day range

Current $378.87

52-week range

Current $378.87

Open
$382.99
Previous close
$380.73
Volume
834.13K
0.54× average
Average volume
1.54M
Average daily volume
Market cap
45.49B USD
Beta
0.74
Market reference 1
50-day average
$382.96
-1.07% below average
200-day average
$271.97
+39.31% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
39.59B USD
EV / EBITDA
13.61×
Earnings yield
3.85%
Free cash flow yield
1.22%

Profitability & efficiency

Return on equity
6.73%
Return on assets
2.44%
Return on invested capital
3.12%

Financial health

Current ratio
0.72×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends20%13%6%-1%Gross margin, FY2021: 17.27%Gross margin, FY2022: 18.54%Gross margin, FY2023: 16.95%Gross margin, FY2024: 14.55%Gross margin, FY2025: 14.54%Operating margin, FY2021: 4.09%Operating margin, FY2022: 3.84%Operating margin, FY2023: 3.12%Operating margin, FY2024: 1.38%Operating margin, FY2025: 1.12%Net margin, FY2021: 3.51%Net margin, FY2022: 3.02%Net margin, FY2023: 2.34%Net margin, FY2024: 1.02%Net margin, FY2025: 0.92%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 17.27%. Gross margin FY2022 18.54%. Gross margin FY2023 16.95%. Gross margin FY2024 14.55%. Gross margin FY2025 14.54%. Operating margin FY2021 4.09%. Operating margin FY2022 3.84%. Operating margin FY2023 3.12%. Operating margin FY2024 1.38%. Operating margin FY2025 1.12%. Net margin FY2021 3.51%. Net margin FY2022 3.02%. Net margin FY2023 2.34%. Net margin FY2024 1.02%. Net margin FY2025 0.92%.

Income trends

Revenue

129.66B USD+10.06%

Operating income

1.45B USD-10.69%

Net income

1.19B USD-1.57%
Income trends across reported periods142.51B USD91.12B USD39.73B USD−11.66B USDRevenue, FY2021: 83.65B USDRevenue, FY2022: 92.92B USDRevenue, FY2023: 106.44B USDRevenue, FY2024: 117.81B USDRevenue, FY2025: 129.66B USDOperating income, FY2021: 3.42B USDOperating income, FY2022: 3.56B USDOperating income, FY2023: 3.32B USDOperating income, FY2024: 1.63B USDOperating income, FY2025: 1.45B USDNet income, FY2021: 2.93B USDNet income, FY2022: 2.81B USDNet income, FY2023: 2.49B USDNet income, FY2024: 1.21B USDNet income, FY2025: 1.19B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 83.65B USD. Revenue FY2022 92.92B USD. Revenue FY2023 106.44B USD. Revenue FY2024 117.81B USD. Revenue FY2025 129.66B USD. Operating income FY2021 3.42B USD. Operating income FY2022 3.56B USD. Operating income FY2023 3.32B USD. Operating income FY2024 1.63B USD. Operating income FY2025 1.45B USD. Net income FY2021 2.93B USD. Net income FY2022 2.81B USD. Net income FY2023 2.49B USD. Net income FY2024 1.21B USD. Net income FY2025 1.19B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue129.66B USD117.81B USD106.44B USD92.92B USD83.65B USD
Cost of goods sold110.81B USD100.66B USD88.39B USD75.69B USD69.2B USD
Gross profit18.85B USD17.15B USD18.05B USD17.23B USD14.45B USD
Operating expenses17.4B USD15.52B USD14.73B USD13.67B USD11.03B USD
Interest expense631M USD660M USD493M USD401M USD326M USD
Depreciation and amortization824M USD968M USD917M USD845M USD713M USD
Operating income1.45B USD1.63B USD3.32B USD3.56B USD3.42B USD
Net income1.19B USD1.21B USD2.49B USD2.81B USD2.93B USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$416.78

10.01% upside
Past 12 months12-month forecastHigh $513Average $416.78Low $300

Rating distribution

44 ratings
Strong buy00%
Buy1636%
Hold2761%
Sell12%
Strong sell00%

HUM peers

ETFs holding HUM

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research HUM

research.disclaimer